Skip to content
Home/Companies/Biotech/Minka Therapeutics

Minka Therapeutics

Biotech·France·Exited 2022·Held 6yr
Entry
2016
Hold
6yr
Exit
2022

Who owns Minka Therapeutics?

Minka Therapeutics is a French Biotech company, formerly owned by Karista, exited in 2022 (exit via MBO). No current private equity owner is on file.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Karista
Investor
Karista
CapDecisif 3 · 2013 · VC

Key facts

HQFrance
SectorBiotech
Exit Type
MBO
Buyer
Management
Exit Year
2022

More from CapDecisif 3

Other portfolio companies in the same fund.

Acticor Biotech
Exited 2025
BiotechFrance· 2017
Endodiag
Endodiag
Active
MedTechFrance· 2017
PayinTech
Active
FintechFrance· 2017
PulseSight Therapeutics
Exited 2019
BiotechFrance· 2017
to Management
Actvt
Active
SoftwareFrance· 2016
E(ye)Brain
E(ye)Brain
Active
MedTechFrance· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Minka Therapeutics?

Minka Therapeutics was formerly owned by Karista, exited in 2022. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue